Lundbeck beats first quarter sales expectations, keeps outlook

COPENHAGEN (Reuters) - Danish drugmaker Lundbeck beat first-quarter sales expectations on Tuesday, helped by strong sales from key drugs which benefitted from stock-piling and longer-lasting prescriptions due to the coronavirus pandemic, it said in a statement. The Copenhagen-based company posted quarterly sales of 4.56 billion Danish crowns ($661.25 million), above an average of 4.34 billion forecast by analysts in a Refinitiv Eikon poll, and an 8% increase from the same period last year...